Antigen and Antibody MCQs

Which pharma organisation has partnered with Merck KGaA and IAVI for development of SARS-CoV-2 neutralizing monoclonal antibodies?

January 3, 2022

5 Views

Which pharma organisation has partnered with Merck KGaA and IAVI for development of SARS-CoV-2 neutralizing monoclonal antibodies?

Q. Which pharma organisation has partnered with Merck KGaA and IAVI for development of SARS-CoV-2 neutralizing monoclonal antibodies?

A. Bharat Biotechnology

B. Serum Institute

C. Cipla

D. Ranbaxy

Answer: Serum Institute

Which pharma organisation has partnered with Merck KGaA and IAVI for development of SARS-CoV-2 neutralizing monoclonal antibodies?

Previous

Which city conducted a Serosurvey and found antibodies against Covid-19 in over 50% of children?

Which pharma organisation has partnered with Merck KGaA and IAVI for development of SARS-CoV-2 neutralizing monoclonal antibodies?

Next

Assam Government Holiday List 2022 – Download PDF

Related Articles

Consider the following pairs:

Consider the following pairs:

Which state-owned institution has approved the project for developing ‘Human monoclonal antibodies (hmAbs)’ that can neutralize the SARS-CoV-2 virus?

Which state-owned institution has approved the project for developing ‘Human monoclonal antibodies (hmAbs)’ that can neutralize the SARS-CoV-2 virus?

Consider the following statements:

Consider the following statements:

In which country, the world’s first baby with antibodies against the novel coronavirus is reported to be born?

In which country, the world’s first baby with antibodies against the novel coronavirus is reported to be born?

We will be happy to hear your thoughts

Leave a reply Cancel reply

You must be logged in to post a comment.